XML 28 R19.htm IDEA: XBRL DOCUMENT v3.26.1
Stock Option Plan
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock Option Plan
9.
Stock Option Plan

The Company adopted the 2020 Equity Incentive Plan, or the 2020 Plan, in June 2020. As of December 31, 2025, there were 222,485 shares reserved for issuance and 953,496 shares available for future grant. The Company reserved 1,140,000 shares for issuance plus a carryover of 7,109 shares from the 2012 Plan for a total of 1,147,109 shares. In addition, returning shares from the 2012 Plan are available for issuance under the 2020 Plan.

Stock options generally vest ratably in either quarterly or annual installments over three or four years, commencing on the first anniversary of the grant date and have contractual terms of ten years. Stock options to directors generally vest ratably over one or two years and have contractual terms of ten years. Stock options are valued using the Black-Scholes option pricing model and compensation is recognized based on such fair value over the period of vesting on a straight-line basis.

 

The following table presents share-based compensation expense on all employee and non-employee awards included in the accompanying statements of operations as follows:

 

For the years ended December 31,

 

(in thousands)

2025

 

 

2024

 

Research and development

$

210

 

 

$

17

 

General and administrative

 

586

 

 

 

418

 

Stock-based compensation expense

$

796

 

 

$

435

 

Stock option activity under the Company's stock options plans for the years ending December 31, 2025 and 2024 were as follows:

(in thousands, except share and per share data)

 

Number of Shares

 

 

Weighted- Average Exercise Price

 

 

Weighted- Average Contractual Term (Years)

 

 

Aggregate Intrinsic Value

 

Outstanding, December 31, 2024

 

 

33,237

 

 

$

153.79

 

 

 

7.15

 

 

$

 

Granted

 

 

196,580

 

 

 

4.33

 

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Cancelled

 

 

(7,332

)

 

 

176.07

 

 

 

 

 

 

 

Outstanding, December 31, 2025

 

 

222,485

 

 

$

23.98

 

 

 

9.04

 

 

$

31

 

Options exercisable, December 31, 2025

 

 

96,435

 

 

$

49.11

 

 

 

8.54

 

 

$

31

 

Options available for future grant, December 31, 2025

 

 

953,496

 

 

 

 

 

 

 

 

 

 

 

On December 31, 2025, total unrecognized compensation costs related to non-vested stock options outstanding amounted to $0.4 million, which is expected to be recognized over a weighted-average period of 1.75 years.

 

The assumptions for volatility, expected life, dividend yield and risk-free interest rate are presented in the table below:

 

 

For the years ended December 31,

 

2025

 

2024

Risk-free interest rate

 

4.05-4.15%

 

3.70 - 4.09%

Expected life in years

 

5.04-6.06

 

5.04-6.06

Expected volatility

 

113.26-127.03%

 

112.17 -170.50%

Expected dividend yield

 

%

 

%